In terms of global demand, Engine Oil Additives Market driven by APAC region with a magnificent 36.9% market share; China holding the leading position for the largest market consumer owing to extensive consumption of passenger and commercial vehicles.

The Report “Engine Oil Additives Market Analysis – By Type (Anti-Oxidants, Detergents, Dispersants, Anti-Wear Additives, VI Improvers, Corrosion Inhibitors, Friction Modifiers, PPD); By Engine Type (Gasoline, Diesel, Natural Gas); By End User (Passenger Car, Commercial Vehicle, Motorcycle) – With Forecast (2015-2020)” publishedby IndustryARC, the market estimated to reach $11.9 billion by 2020

Engine Oil Additives are specialty chemicals mixed with the engine oil to enhance its properties. These additives help in protecting the engine from any wear & tear and also improve the overall fuel economy. The market is segmented on the basis of different types of additives such as anti-oxidants, detergents, dispersants, anti-wear additives, VI improvers, corrosion inhibitors, friction modifiers, pour point depressants and others. Market is also segmented based on different engine types and end users.

Engine oil additives market had sales revenue of around $9.9 billion in 2014, where APAC dominated with around 37% revenue share. Increasing number of in-use vehicles as well new registrations in APAC region is driving the market growth. China, among all the countries is the promising market with rising demand for engine oil additives. China being the country for highest number of motorcycles on road plays a major role in the global engine oil additives market.

For an Inquiry about the Report: http://www.industryarc.com/inquiry-before-buying.php?id=7509

The market is analyzed by the following end user verticals:

• Passenger car
• Commercial vehicles
• Motorcycles
• Others

The global in use passenger car fleet has been increasing; hence engine oil additives market volume for passenger car is estimated to grow at a CAGR of 4.3% from 2014 to 2020. Across Americas, the number of commercial vehicles in use is very high, accounting for 52.2% of the global commercial vehicle in use fleet in 2014. Due to this reason, America leads the engine oil additives market for commercial vehicles, followed by Europe and APAC.

Following key players were also covered as part of the market landscape analysis:

• Chemtura Corporation
• Lubrizol Corporation
• Croda International Plc
• BASF SE
• Evonik Oil Additives USA Inc.

Globally there are many manufacturers listed in the engine oil additives market including many small and medium scale regional players. Out of all those only a few as stated above are competing in the global market. Every company is investing huge share of their profitability for R&D to come up with innovative products to differentiate themselves in the market. Engine oil additives market is set to experience a lot of change in future in terms of demand and other technical aspects.

Request for a Sample Market Brochure @ http://www.industryarc.com/pdfdownload.php?id=7509

Browse Related Reports:

• Lubricants Market – Lubricants Market: By Type (Engine Oil, Gear Oil, Hydraulic Fluid, Metalworking Fluids, Greases, Turbine Oil, Compressor Oil, Others) Base Oil (Mineral, Synthetic, Bio-based, Others) Application (Automotive, Industrial, Others)-Forecast(2015 – 2020) http://industryarc.com/Report/11709/lubricants-market-analysis.html

• Demulsifier Market – Demulsifier Market By Type (Oil Soluble and Water Soluble), By Application (Crude Oil, Petro Refineries, Lubricants and Others) & By Geography – Forecast (2015-2020) http://industryarc.com/Report/11688/demulsifier-market-analysis.html

About IndustryARC:

IndustryARC is a Research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2016/03/1459413563.jpeg

“Europe: A potential revenue market during the forecast period despite APAC and the Americas leading the global market currently.”

Media Contact
Company Name: IndustryARC
Contact Person: Mr. Sanjay Matthews
Email: sales@industryarc.com
Phone: 1-614-588-8538 (Ext: 101)
Country: United States
Website: http://www.industryarc.com

Source: ABNewswire

ReleaseID: 57830

With 137 tables and figures ‘Global Smart Home System Industry 2016 Market Research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

The Global Smart Home System Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Smart Home System industry. The report provides a basic overview of the industry including definitions and classifications. The Smart Home System market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Key companies of Smart Home System profiled in this report are ABB, Control4 Corporation, Lutron Electronics, Crestron Electronics, Emerson Electric, Ingersoll-Rand, Legrand, Lutron Electronics, Schneider Electric, Siemens, and Tyco.

Browse Report at: http://www.reportsweb.com/global-smart-home-system-industry-2016-market-research-report

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

Buy this Exclusive Report at: http://www.reportsweb.com/buy&RW0001176408/buy/2800

Table of Contents:

1 Industry Overview

2 Smart Home System International and China Market Analysis

3 Environment Analysis of Smart Home System

4 Analysis of Revenue by Classifications

5 Analysis of Revenue by Regions and Applications

6 Analysis of Smart Home System Revenue Market Status 2011-2016

7 Analysis of Smart Home System Industry Key Manufacturers

8 Sales Price and Gross Margin Analysis

9 Marketing Trader or Distributor Analysis of Smart Home System

10 Development Trend of Smart Home System Industry 2016-2021

11 Industry Chain Suppliers of Smart Home System with Contact Information

12 New Project Investment Feasibility Analysis of Smart Home System

13 Conclusion of the Global Smart Home System Industry 2015 Market Research Report

Get Discount on this Report at: http://www.reportsweb.com/inquiry&RW0001176408/discount

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2016/03/1455115183.png

“Global Smart Home System Industry 2016 Market Research Report”

Media Contact
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Email: sales@reportsweb.com
Phone: +1-646-491-9876
Country: United States
Website: http://www.reportsweb.com/global-smart-home-system-industry-2016-market-research-report

Source: ABNewswire

ReleaseID: 57828

The BOGE airstatus remote diagnostic tool ensures maximum reliability.

Victoria, Australia – March 31, 2016 – (http://www.boge.com.au) The BOGE airstatus is based on pioneering technology that redefines the communications between man and machine in the Industry 4.0 age. This remote diagnostics tool by BOGE is a new solution which increases safety and transparency in compressed air production and all associated components. This tool maintains the high-level performance and efficiency of your compressed air station and is ideally suited for monitoring and managing complex systems and plants.

With airstatus, users have the status of up to 32 components firmly under control – from anywhere in the world. Process data such as status, maintenance messages, temperatures and pressures are directly transmitted and displayed, making airstatus a powerful remote diagnostics tool. Users can identify, analyze and react immediately to fault messages on their own computer or smartphone, considerably reducing the time needed to rectify faults. Or you can use the BOGE airstatus for condition monitoring in order to manage proactive measures and to plan and coordinate maintenance work. All of this can be easily managed using the BOGE airstatus app, which works with all mobile iOS and Android devices.

Easy installation, lasting safety:

A ModbusScan to detect each of the compressors and components makes it easy to commission the BOGE airstatus monitoring facility. The system data communication is processed in real-time via GSM/GPRS or a LAN connection. Users can view data in the BOGE airstatus web portal or in the BOGE airstatus APP. Alarm management by email or SMS if defined limits are exceeded or undercut provides an additional safety feature.

Customized packages to suit every client’s needs:

There are five different packages available with successively comfortable features. These range from the “local monitoring” package with hardware, web portal use and APP, to the mobile monitoring package with an additional SIM card (D/EU) right up to a premium monitoring package which even includes an iPhone. The premium maintenance provides BOGE customers with both full transparency through the BOGE airstatus web portal and APP and also a maintenance contract which includes full system monitoring and maintenance.

Users can find out more about the technical details and options offered by BOGE Kompressoren by visiting www.boge.com.au?

About BOGE Compressors:

BOGE Compressors Australia Pty Ltd is a subsidiary Company of BOGE KOMPRESSOREN Otto Boge GmbH & Co. KG based in Germany. With more than 100 years of experience in mechanical engineering, BOGE KOMPRESSOREN Otto Boge GmbH & Co. KG is one of the oldest manufacturers of compressors and compressed air systems in Germany. Whether for high speed turbo compressors, screw compressors, piston compressors, scroll compressors, complete systems or individual devices, BOGE meets the most diverse requirements and highest standards – in a precise and quality-aware manner. BOGE solutions are used by all sectors of industry to supply compressed air for a wide range of manufacturing processes. The product is sold and serviced through a dedicated network of distributors throughout Australia and New Zealand.

Image: http://www.getnews.info/uploads/e614d987d748882bcacc379c90885bb6.jpg

Logo: http://www.getnews.info/wp-content/uploads/2016/03/1459395592.jpeg

Media Contact
Company Name: BOGE Compressors (Australia) Pty Ltd
Contact Person: Jim Rohner, General Manager
Email: j.rohner@boge.com
Phone: +61 03 5940 3266 / Fax: +61 03 5940 9279
Address:49 National Avenue
City: PAKENHAM
State: Victoria
Country: Australia
Website: www.boge.com.au

ReleaseID: 542245

Source: GetNews

• Creates a dedicated practice to address the increasing requirements in non-relational databases such as Mongo DB
• Forms a core team to innovate and create advanced solutions

Clover Infotech, a leading IT services company and one of the most preferred service providers for relational database management has announced a practice to cater to non-relational database management systems.

The step is intended to address the increasing demand from its banking and insurance customers to create a cost-effective analytics & big data infrastructure. This comes as a logical extension to Clover Infotech’s extensive experience and expertise spanning over 2 decades in database management services. The company has also established a core team to innovate further on NoSQL technologies and create efficient solutions for its customers as per their evolving needs. With the increasing influence of social, mobility and cloud, humungous volumes of data is generated and this “practice” team at Clover Infotech enables customers to develop new age applications around NoSQL to manage this data.

Commenting on this development, Deepesh Upadhye, VP – Technology, and head of this practice, said, “The NoSQL database revolution will create a diverse set of opportunities in data collation, management and analysis. At Clover Infotech, we look forward to this opportunity and will help our customers to leverage the potential of NoSQL technologies in the best possible manner.”

Clover Infotech is highly sought for its database management services and has been conferred the CIO Choice awards for three consecutive years from 2013 to 2015. However, it has also been enabling its customers to take an informed decision to move onto NoSQL platforms by conducting extensive feasibility study of their current infrastructure. The Clover Infotech team further undertakes designing of the architecture, development of applications for NoSQL databases, implementation of NoSQL databases such as MongoDB and comprehensive support. 

About Clover Infotech

Founded in 1994, Clover Infotech (www.cloverinfotech.com) is a comprehensive IT services provider with strong presence in India and Singapore. Over the years, Clover Infotech has established its expertise across multiple technologies including Oracle, SAP, Microsoft and Open Source.

Equipped with ISO 27001 delivery centers, Clover Infotech has been providing services ranging from Application services to Infrastructure management services to over 200 customers across geographies and industry verticals. The company has a keen focus on the BFSI space. Its clientele in India comprises the leading private sector banks and insurance houses.

Clover Infotech is a recipient of the CIO Choice awards (three consecutive years: 2013, 2014 and 2015) in the category ‘Database Solutions Support’. The company has also been conferred with the CIO Choice 2014 in the category ’Application Delivery Platform’.

Logo: http://www.getnews.info/wp-content/uploads/2016/03/1459404710.png

The NoSQL database revolution will create a diverse set of opportunities in data collation, management and analysis. At Clover Infotech, we look forward to this opportunity and will help our customers to leverage the potential of NoSQL technologies in the best possible manner, said Deepesh Upadhye, VP – Technology

Media Contact
Company Name: Clover Infotech
Contact Person: Vimal Pillai
Email: Vimal.pillai@cloverinfotech.com
Phone: 9930822074
Country: India
Website: www.cloverinfotech.com

ReleaseID: 542249

Source: GetNews

In the City of Copenhagen a small team of hard working data rebels has developed a revolutionising data extraction and intelligence tool, dexi.io. After three years of bootstrap development by the co-founder, and today the CTO at dexi.io, Henrik Hofmeister, the company launched in the summer of 2015 and finally received its first round of funding!

Complete Big Data Tool for Professionals

Recently dexi.io relaunched the platform and besides rebranding from its early stage name CloudScrape, dexi has also released a new product, Pipes, adding an intelligent data transformation tool to complement its advanced point and click web data extraction tool. More than 10.000 companies are now using the platform, executing more than 2 million robots!

Driving Innovation is the Key to Success

Dexi.io has a bit of an untraditional organisation. The sales department has been replaced with an innovation team and for a good reason. As Stefan Avivson, CEO of dexi.io explains: “Although Robotic Process Automation (RPA) is not a new concept, service providers have been using so called Robotic Processing for a decade now, but the amount of available data and the technology to process it has evolved tremendously over the past two years. There is basically no real limitation to the use of Big Data and there is no real effort in convincing people that RPA is the future. It’s more a question of knowing how! Utilising the resources of our innovation team to clients and partners has without doubt been one of the key drivers to our success!”

Smart City, Hitachi & City Data Exchange

Due to the complex technology in use but despite being a very young company, dexi.io is already involved in some prestigious projects making the world a better place with the use of Big Data. One of these projects is the City Data Exchange being launched in April 2016.

The City Data Exchange is a big data exchange run by Hitachi Consulting and the project is part of the European Smart City project with the goal of using data for a smarter future. “The European Commission is investing no less than €200m in Smart Cities in the next two years and this is a great opportunity for dexi.io to be in the center of data driven innovation”, explains head of the innovation team and Executive Officer at dexi.io Jacob Laurvigen. He continues: “No doubt this will help drive data innovation even further in the years to come!”

Image: http://www.getnews.info/uploads/c59a040e7494534e8b646c2be9d9103e.jpg

About us:

Based in Copenhagen, Denmark, dexi.io is a Cloud-based, high-performance, feature-rich application with visual editors for building custom data extraction and refinement solutions. We are trusted by thousands around the world to extract, enrich, and connect the valuable data our clients depend on.

Media Contact
Company Name: Dexi.io
Contact Person: Jacob Laurvigen, Executive Officer
Email: jal@dexi.io
Phone: +45 31 53 16 00
City: Copenhagen
Country: Denmark
Website: http://dexi.io/

ReleaseID: 542256

Source: GetNews

Its creator, bestselling author Teresa Anne Power, says at 11 a.m., over 21,000 kids will spend five minutes at schools and other places doing fun yoga poses and celebrating fitness.

On April 8th, from 11:00 A.M. to 11:05 A.M., thousands of schoolchildren around the world, including those in at least 45 states in the U.S., will put down their books and let their imaginations run free as they mold themselves into trees, flamingos, windmills, kites, and other kid-friendly positions.

They will be joined by children at home and other locations, all led by more than 100 official ambassadors to raise global awareness about yoga for kids. It’s all part of the first annual Kids’ Yoga Day  envisioned by Teresa Anne Power, a bestselling author whose latest book, ‘The ABCs of Yoga for Kids: A Guide for Parents and Teachers,” is being released that day.

An internationally recognized expert on children’s yoga and author of the beautifully illustrated “The ABCs of Yoga for Kids” – a book that has sold more than 1/4 million copies in four languages – Power says few people understand how powerful yoga can be.

More than a great way to become fit, she says parents who practice yoga with their children get a bonus: stronger relationships with them. “When you both do something healthy and fun, you will get closer,” she observes, noting that the type of yoga she favors is playful and does not involve chanting.

About Teresa Anne Power

Teresa Anne Power is an avid yoga practitioner, teacher and speaker who has been featured in USA Today, on Fox 11 in Los Angeles, and other major media. She volunteers at Let’s Move West LA, Children’s Bureau, Connections for Children, and other places. Her mission is to spread the world about the benefits of yoga to as many children as possible. Kids’ Yoga Day is expected to draw over 21, 000 participants.

Availability: Nationwide by telephone and arrangement

Logo: http://www.getnews.info/wp-content/uploads/2016/03/1459424980.jpeg

Media Contact
Company Name: ABC Yoga for Kids
Contact Person: Teresa Anne Power
Email: info@kidsyogaday.com
Phone: 310-266-7705
City: Pacific Palisades
State: CA
Country: United States
Website: http://www.abcyogaforkids.com/

ReleaseID: 542241

Source: GetNews

March 31, 2016 – – BloodThinnerHelp.com reports on substantial similarities discovered between Xarelto and Pradaxa lawsuits, which help to bring encouragement to current Xarelto lawsuit plaintiffs as they await early 2017 bellwether trials. Xarelto lawsuit numbers appear to be continually increasing. Today, complaints which were federally-filed have been transferred and consolidated to a single court by the U.S. Judicial Panel on Multidistrict Litigation, forming MDL No. 2592. These lawsuits reportedly now number more than 2,800, and they are not alone. Another group of more than 600 Xarelto lawsuits has been consolidated by the Court of Common Pleas in Philadelphia, Pennsylvania to form a mass tort program.

Xarelto lawsuits consolidated in the MDL located in Eastern Louisiana and are currently being overseen by the Honorable Judge Eldon Fallon. All complaints share strikingly similar allegations against defendants Bayer AG and Janssen Pharmaceuticals, (a division of Johnson & Johnson).

Xarelto was approved by the U.S. Food and Drug Administration and was released to market in 2011. The drug is a new-generation blood thinner and was very popular, as it provided patients dependent upon blood thinners with freedoms that traditional blood thinners had been unable to. Xarelto was developed and approved to treat patients recovering from hip and knee replacement surgeries, pulmonary embolism, deep vein thrombosis, or atrial fibrillation.

Pradaxa is a similar new-generation anticoagulant drug, which was marketed by Boehringer Ingelheim in October of 2010. Like Xarelto, it did not take long after the blood thinner’s initial market release for it to become the topic of more than 3,500 adverse event reports to the FDA. More than 750 of these FDA adverse event reports detailed fatalities which were reportedly experienced by patients using the drug. Within a short time, Pradaxa became the subject of over 4,000 lawsuits, and plaintiffs filing the lawsuits were anxiously awaiting trial, hoping for what they believed to be justice. The evening before the trial was scheduled to take place, however, defendant Boehringer Ingelheim chose to settle the lawsuits by paying $650 million to the involved plaintiffs.

Today, Xarelto lawsuit plaintiffs look to this past settlement with many similarities and find encouragement that their current pursuits will bring them what they deem to be justice as the trial dates approach. These lawsuits continue to grow in number and are currently scheduled for bellwether trial hearings in early 2017.

As thousands of Xarelto lawsuit plaintiffs await further legal action, Attorney Joseph Osborne is working to help ensure that others who believe that they were negatively affected by using Xarelto will be given an opportunity to investigate their legal rights in the matter. Affected individuals may be entitled to legal action and significant compensation. To assist those needing it, Attorney Osborne is offering complimentary Xarelto consultations for involved parties at this time.

To ask questions concerning Xarelto lawsuits, or to request additional information, please contact Attorney Joseph Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009003

March 31, 2016 – – ZofranLegal.com reports on a lawsuit which was filed in Louisiana against GlaxoSmithKline in reference to the anti-nausea drug they manufacture, Zofran. The plaintiffs filing the complaint are parents to a young boy, who allege that fetal exposure to Zofran through the mother caused their son to develop serious congenital heart defects. They claim that his specific defects are known as atrial septal defect and partial anomalous pulmonary venous return.

Partial anomalous pulmonary venous return is a rare congenital heart defect. It causes blood within the pulmonary vein to circulate improperly and return to the heart’s right atrium instead of the left atrium. Atrial septal defect happens when the heart wall (or septum) develops a hole generally separating its chambers and hindering the blood pumping process. The hole exposes oxygen rich blood to oxygen poor blood within the heart. A child born with both of these heart defects could have difficulty getting oxygenated blood and can often appear to have a bluish tinge to their skin, fingernails, or other areas of the body.

Court documents further detail that the boy’s mother claims to have been prescribed Zofran by her doctor during her first trimester of pregnancy as a morning sickness treatment. While the first trimester is a common time for expectant mothers to battle nausea and vomiting episodes, it is also a time when the fetus’ cells undergo rapid division and initial heart, mouth, and limb tissue formation occurs.

This mother is not alone in her claims. Across the nation, hundreds of other parents have filed lawsuits against GSK alleging that Zofran exposure caused their children to develop a range of birth defects. These plaintiff also commonly share a specific frustration: Zofran was never FDA-approved to treat pregnant women or tested for safety on this consumer group and their unborn babies. Despite this concerning and controversial fact, however, GSK marketed their drug “off-label” as a safe and effective treatment for morning sickness and also advertised it this way to Ob/Gyns and the general public, leading to mass “off-label” prescriptions.

As involved plaintiffs await what they are hoping to consider justice, the attorneys of Monheit Law are working to help other women who have used Zofran while pregnant and have later given birth to children with defects. Affected individuals may be entitled to significant compensation attained through legal action. To help these patients investigate their legal rights in full, Monheit Law is currently offering complimentary legal consultations for qualified parties.

To request additional Zofran birth defect lawsuit information, or to ask questions, please contact Michael Monheit, Esq., lead attorney of Monheit Law, by calling (877) 620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60009002

March 31, 2016 – – TheProductLawyers.com reports on recent allegations surrounding type-2 diabetes drug Invokana, which link the use of the drug to possibly severe kidney risks. The U.S. Food and Drug Administration states that they have received 50 reports of adverse events concerning patients who have used Invokana and have developed renal impairment and kidney failure in the drug’s initial year on the market alone.

Invokana was approved by the FDA in March of 2013 as a new-generation type-2 diabetes medication. It is one of a group of similar drugs released known as SGLT2 class inhibitors, which is an abbreviation for sodium-glucose cotransporter-2. The drug works by helping type-2 diabetes patients to maintain their glucose or blood sugar levels. It accomplishes this by preventing the kidneys from absorbing excess sugar and instead ridding the body of that excess sugar through urination.

Working in this fashion means that Invokana relies heavily on the kidneys, which may also mean that it can pose a serious health risk for those organs, especially among patients who have pre-existing kidney damage, which can be a common side effect of diabetes. The announcement of this potential side effect has understandably caused concern among those currently relying on Invokana or another SGLT2 class inhibitor drug to help manage their diabetes.

The attorneys of Banville Law understand the importance of keeping the public informed of the latest updates concerning potential side effects such as these. They work daily to provide the public with current information on Invokana and other similar SGLT2 class inhibitor drugs. To accomplish this, they sponsor the online resource website TheProductLawyers.com, and are also currently helping anyone who has used these drugs and has suffered from medical complications that they believe were caused by the drugs. These individuals deserve the important opportunity to fully explore their legal rights in the matter. Affected patients could be entitled to substantial compensation attained through legal action. To assist those looking at the possibility of legal action, the attorneys of Banville Law are also currently offering free legal consultations for qualified individuals.

To ask questions regarding Invokana lawsuits, or to request additional information on SGLT2 class inhibitor drugs, please contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009001